Optimization of a clinical stage nanoparticle drug delivery platform
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA186410
- Recipient
-
Dicerna Pharmaceuticals, Inc. UEI UPKXGEA9AKT6
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,998,609
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Cambridge, MA 02140, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $998,609 | |
| Original award | $1,000,000 |
Quick answers
Who received award R44CA186410?
R44CA186410 was awarded to Dicerna Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 1, 2016.
How much is award R44CA186410 worth?
$1,998,609 has been obligated on R44CA186410.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award